SCHEMBL22414714

SCHEMBL22414714

O=C(COc1cc2ccccc2c2ccccc12)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 1/20 0.53
▸ TNKS O95271 1/20 0.53
▸ PARP1 P09874 1/20 0.53
▸ ROCK1 Q13464 1/20 0.53
▸ PARP14 Q460N5 1/20 0.53
▸ PARP10 Q53GL7 1/20 0.53
▸ PARP2 Q9UGN5 1/20 0.53
▸ PARP3 Q9Y6F1 1/20 0.53
▸ TDP1 Q9NUW8 3/20 0.53
▸ L3MBTL1 Q9Y468 2/20 0.53
▸ KMT2A Q03164 5/20 0.49
▸ MEN1 O00255 4/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ KDM4E B2RXH2 2/20 0.47
▸ HPGD P15428 1/20 0.47
▸ GPR84 Q9NQS5 1/20 0.46
▸ DAPK1 P53355 1/20 0.44
▸ PIM3 Q86V86 1/20 0.44
▸ ADORA3 P0DMS8 1/20 0.44
▸ LMNA P02545 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22414662 0.88 MAPT (0.50) ROCK2TNKSPARP1ROCK1PARP14
SCHEMBL22414866 0.88 MAPT (0.46) ROCK2TNKSPARP1ROCK1PARP14
SCHEMBL22414749 0.88 ROCK2 (0.46) ROCK2TNKSPARP1ROCK1PARP14
SCHEMBL22414878 0.86 ROCK2 (0.47) ROCK2TNKSPARP1ROCK1PARP14
SCHEMBL22414669 0.86 ROCK2 (0.47) ROCK2TNKSPARP1ROCK1PARP14
SCHEMBL10260277 0.82 ROCK2 (0.73) ROCK2TNKSPARP1ROCK1PARP14
SCHEMBL6224144 0.81 ALDH1A1 (0.73) ROCK2TNKSPARP1ROCK1PARP14
SCHEMBL11643261 0.78 TDP1 (0.53) ROCK2TNKSPARP1ROCK1PARP14
SCHEMBL11717986 0.78 CASP3 (0.66) ROCK2TNKSPARP1ROCK1PARP14
SCHEMBL9787048 0.77 L3MBTL1 (0.73) ROCK2TNKSPARP1ROCK1PARP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127951-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO LTD (KR) 2023-04-27 — — US disclosed
US-20230127951-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO LTD (KR) 2023-04-27 — — US disclosed
US-20200283426-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2020-09-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127951-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SLC25A21, SLCO4C1, SLCO2A1 ROCK2 4657/4885TNKS 2745/4885PARP1 1799/4885
US-20200283426-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE USE1, SLC16A1, SLCO4C1 ROCK2 4630/4885TNKS 1975/4885PARP1 1147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback